Independent Advisory Group (Tayside Breast Cancer) report
This report makes 19 recommendations for medicines governance following allegations of under-dosing of two oncology medicines included in the chemotherapy regimen known as the FEC-T (fluorouracil, epirubicin, cyclophosphamide and docetaxel) (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - August 28, 2019 Category: Consumer Health News Source Type: news
docetaxel (Taxotere, Docefrez)
Title: docetaxel (Taxotere, Docefrez)Category: MedicationsCreated: 3/12/2000 12:00:00 AMLast Editorial Review: 8/22/2019 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - August 22, 2019 Category: Cancer & Oncology Source Type: news
Researchers confirm the validity of xenographic models for studies of methylation
(IDIBELL-Bellvitge Biomedical Research Institute) Researchers at the Bellvitge Biomedical Research Institute (IDIBELL), published today in Molecular Cancer Research a study where they identify methylation patterns associated with different subtypes of breast cancer, and a subclassification of the group of " triple negatives " , a breast cancer type typically associated with poor prognosis. In addition, researchers identified changes in DNA methylation associated with the response to docetaxel, a common therapy. The research was led by Dr. Eva Gonz á lez-Su á rez, head of the IDIBELL Transformation and Metastasis research...
Source: EurekAlert! - Cancer - July 18, 2019 Category: Cancer & Oncology Source Type: news
Company led recall – Docetaxel Injection 160mg/16ml and 20mg/2ml
Pfizer UK Limited isrecalling batches as routine stability testing has identified that levels of a known impurity, 10-oxo-docetaxel, may exceed the acceptable level at the end of shelf-life.
Further (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - June 24, 2019 Category: Drugs & Pharmacology Source Type: news
Can T-DM1 Match Chemotherapy Plus Dual Blockade in HER2+ Breast Cancer?
A phase II trial tested docetaxel, trastuzumab, and pertuzumab vs T-DM1 for the neoadjuvant treatment of HER2+ breast cancer. (Source: CancerNetwork)
Source: CancerNetwork - June 14, 2019 Category: Cancer & Oncology Authors: Dave Levitan Source Type: news
Dr. Gadgeel on Docetaxel Plus Trametinib in KRAS-Mutated Recurrent NSCLC
In this video, Shirish M. Gadgeel, MD, of Rogel Cancer Center, University of Michigan, discusses combo docetaxel/trametinib in G12C or non-G12C KRAS mutation-positive, recurrent NSCLC. (Source: CancerNetwork)
Source: CancerNetwork - June 10, 2019 Category: Cancer & Oncology Authors: Shirish M. Gadgeel, MD Source Type: news
Can Metformin Improve Outcomes When Added to Chemotherapy in Prostate Cancer?
The TAXOMET trial tested the addition of metformin to docetaxel and prednisone in patients with metastatic castration-resistant prostate cancer. (Source: CancerNetwork)
Source: CancerNetwork - June 6, 2019 Category: Cancer & Oncology Authors: Dave Levitan Source Type: news
Better Longer-Term Survival in NSCLC After Nivolumab Response Better Longer-Term Survival in NSCLC After Nivolumab Response
Previously treated patients with advanced NSCLC who responded to nivolumab had long-term survival that was notably higher than patients who received docetaxel.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 8, 2019 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news
Docetaxel Chemo Ups Survival in High - Risk Localized Prostate Cancer
Findings based on addition of docetaxel chemotherapy to androgen suppression, radiotherapy (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - March 29, 2019 Category: Cancer & Oncology Tags: Oncology, Pharmacy, Urology, Journal, Source Type: news
Docetaxel Chemo Ups Survival in High-Risk Localized Prostate Cancer
THURSDAY, March 28, 2019 -- Adding docetaxel-based chemotherapy (CT) to standard treatment for high-risk nonmetastatic prostate cancer improves survival, according to a study published online March 12 in the Journal of Clinical Oncology.
Seth A.... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - March 28, 2019 Category: Pharmaceuticals Source Type: news
